June 14, 2022
Jack Resneck Jr., M.D., a dermatologist and health policy expert from San Francisco, will be installed this evening as the next president of the American Medical Association (AMA).
Dr. Resneck previously served as a member of the AMA Board of Trustees and is a frequent spokesman on issues related to public health, having testified in in congressional hearings on the topics of telemedicine, digital health, rising prescription drug prices, prior authorization, and other challenges facing the U.S. health care system.
"On behalf of the nearly 50,000 members of the California Medical Association (CMA), we are extremely proud of California’s own, Jack Resneck, Jr., M.D., as he is installed as president of the American Medical Association," said CMA President Robert E. Wailes, M.D. "As America’s physicians continue to meet the COVID-19 challenge with heroic efforts, it is reassuring to know that Dr. Resneck will be at the helm, harnessing our collective power to advocate for our profession, our patients and our communities."
First elected to the AMA Board of Trustees in 2014, Dr. Resneck held the office of board chair from 2018 to 2019. Prior to serving on the board, Dr. Resneck chaired the AMA Council on Legislation and as a delegate in the AMA House of Delegates. Additionally, he has held several leadership positions in organized medicine, including president of the California Society for Dermatology and Dermatologic Surgery, board member at the American Academy of Dermatology, and is an active member of the California Medical Association.
In addition to caring for patients with a wide range of skin diseases in Northern California, Dr. Resneck has devoted his efforts to training the next generation of physicians. He is the vice chair and professor of dermatology at the University of California, San Francisco (UCSF) School of Medicine, where he directed the dermatology residency program for several years, with a joint appointment at the Philip R. Lee Institute for Health Policy Studies.